Real-world evidence, describing patient reported outcomes caregiver burden, cost of illness and healthcare resource utilisation associated with different conditions and treatment strategies, is of enormous value to payers and regulatory bodies. This evidence is essential to drive improved outcomes for patients and guide efficient healthcare resource allocation.
Adelphi Real World are experts in conducting HEOR using a range of methodologies.
Our real-world Disease Specific Programmes™ include general and disease specific PRO measures along with a range of healthcare resource utilisation variables capturing data from both the physician and the patient perspective. Data are available in over 60 distinct therapy areas.
HEOR studies are also conducted by the Bespoke team (tailored non-interventional studies) and Generate team (database analyses) using medical chart reviews, secondary data sources and patient and caregiver questionnaires.
Market Understanding 
Clinical Outcomes 
Feasibility 
Market Access